2026 Emma Guttman-Yassky: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	110	506	468	306	278	382	42093
Medicine	110	5591	5253	3007	2788	385	42122

Overview

Emma Guttman-Yassky is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Dermatology, Immunology, Allergy, Physiology, and Rheumatology.

The scientist's main areas of study include:

Dermatology and Skin Diseases
Allergic Rhinitis and Sensitization
Asthma and respiratory diseases
Food Allergy and Anaphylaxis Research
Urticaria and Related Conditions
IL-33, ST2, and ILC Pathways
Hair Growth and Disorders

Emma Guttman-Yassky has contributed to numerous publications found predominantly in the following venues:

Journal of Investigative Dermatology
Journal of the American Academy of Dermatology
Allergy
Journal of Allergy and Clinical Immunology
British Journal of Dermatology

Some of their recent significant papers include:

"Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)*" (2020, British Journal of Dermatology)
"Type 2 immunity in the skin and lungs" (2020, Allergy)
"Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials" (2021, The Lancet)
"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis" (2020, Journal of Allergy and Clinical Immunology)
"Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials" (2020, British Journal of Dermatology)

Their collaborative network includes frequent co-authorship with:

Ester Del Duca
Yeriel Estrada
Jonathan I. Silverberg
James G. Krueger
Eric L. Simpson

The broad thematic span of their work engages with immune-related mechanisms, especially within the context of dermatological and allergic diseases. The volume and venues of publication indicate an active role in advancing understanding in areas such as atopic dermatitis, immune system pathways, and related clinical interventions.

Best Publications

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

Eric L. Simpson;Thomas Bieber;Emma Guttman-Yassky;Lisa A. Beck

2113
Citations
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.

Lisa A. Beck;Diamant Thaçi;Jennifer D. Hamilton;Neil M. Graham

1539
Citations
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.

Julia K. Gittler;Julia K. Gittler;Avner Shemer;Mayte Suárez-Fariñas;Judilyn Fuentes-Duculan

1047
Citations
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

K.E. Nograles;L.C. Zaba;E. Guttman-Yassky;J. Fuentes-Duculan

957
Citations
IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells

Kristine E. Nograles;Lisa C. Zaba;Avner Shemer;Judilyn Fuentes-Duculan

764
Citations
Integrative Responses to IL-17 and TNF-α in Human Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis

Andrea Chiricozzi;Emma Guttman-Yassky;Emma Guttman-Yassky;Mayte Suárez-Fariñas;Kristine E. Nograles

732
Citations
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies

Patrick M. Brunner;Emma Guttman-Yassky;Donald Y.M. Leung

665
Citations
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis

Emma Guttman-Yassky;Emma Guttman-Yassky;Robert Bissonnette;Benjamin Ungar;Benjamin Ungar;Mayte Suárez-Fariñas

661
Citations
The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization.

Shinji Noda;Mayte Suárez-Fariñas;Benjamin Ungar;Benjamin Ungar;Soo Jung Kim

650
Citations
Atopic dermatitis endotypes and implications for targeted therapeutics.

Tali Czarnowicki;Helen He;James G. Krueger;Emma Guttman-Yassky;Emma Guttman-Yassky

638
Citations
Cellular and molecular immunologic mechanisms in patients with atopic dermatitis

Thomas Werfel;Jean-Pierre Allam;Tilo Biedermann;Kilian Eyerich

617
Citations
Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*

A. Wollenberg;A. Blauvelt;E. Guttman‐Yassky;M. Worm

564
Citations
Deciphering the Complexities of Atopic Dermatitis: Shifting Paradigms in Treatment Approaches

Donald Y.M. Leung;Emma Guttman-Yassky

559
Citations
Type 2 immunity in the skin and lungs.

Cezmi A. Akdis;Peter D. Arkwright;Marie-Charlotte Brüggen;William Busse

549
Citations
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.

Eric L. Simpson;Amy S. Paller;Elaine C. Siegfried;Mark Boguniewicz

528
Citations
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.

Jennifer D. Hamilton;Mayte Suárez-Fariñas;Nikhil Dhingra;Irma Cardinale

518
Citations
Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis

Mayte Suárez-Fariñas;Nikhil Dhingra;Nikhil Dhingra;Julia Gittler;Julia Gittler;Avner Shemer

513
Citations
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities.

Mayte Suárez-Fariñas;Suzanne J. Tintle;Avner Shemer;Andrea Chiricozzi;Andrea Chiricozzi

500
Citations
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Emma Guttman-Yassky;Henrique D. Teixeira;Eric L. Simpson;Kim A. Papp

499
Citations
Treatment of atopic dermatitis with tralokinumab, an anti-IL-13 mAb.

Andreas Wollenberg;Michael D. Howell;Emma Guttman-Yassky;Jonathan I. Silverberg

477
Citations
Contrasting pathogenesis of atopic dermatitis and psoriasis—Part I: Clinical and pathologic concepts

Emma Guttman-Yassky;Emma Guttman-Yassky;Kristine E. Nograles;James G. Krueger

435
Citations

Frequent Co-Authors

James G. Krueger Rockefeller University

Mayte Suárez-Fariñas Icahn School of Medicine at Mount Sinai

Eric L. Simpson Oregon Health & Science University

Judilyn Fuentes-Duculan Rockefeller University

Jonathan I. Silverberg George Washington University Hospital

Amy S. Paller Northwestern University

Lisa A. Beck University of Rochester Medical Center

Lawrence F. Eichenfield University of California, San Diego

Mark Lebwohl Icahn School of Medicine at Mount Sinai

Kenji Kabashima Kyoto University

External Links

Personal website of Emma Guttman-Yassky

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring Immunology often opens doors to various healthcare and research careers. For those interested in clinical practice, pursuing a nursing path can be a rewarding option. Programs like the easiest nurse practitioner program provide flexible routes to entering the field without compromising quality.

Specialties such as psychiatric mental health nursing are increasingly in demand. Prospective students should consider accredited options like the top pmhnp programs, which emphasize strong clinical placements, essential for hands-on experience.

Budget-conscious learners can find value through the cheapest psychiatric nurse practitioner programs, which offer quality education at a lower cost, helping to ease financial barriers while maintaining rigorous training standards.

Advancing education to the doctoral level also impacts earning potential. Insights into the doctorate in nursing salary provide valuable context for understanding the financial benefits of higher nursing degrees, informing long-term career planning.